UK Markets open in 4 hrs 3 mins

Sanofi (SNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
49.88-1.62 (-3.15%)
At close: 4:00PM EDT
49.99 +0.11 (0.22%)
After hours: 05:18PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close51.50
Open50.48
Bid50.17 x 800
Ask50.18 x 1200
Day's range49.87 - 50.85
52-week range44.76 - 54.26
Volume2,815,181
Avg. volume1,369,660
Market cap124.774B
Beta (5Y monthly)0.40
PE ratio (TTM)8.63
EPS (TTM)5.78
Earnings dateN/A
Forward dividend & yield1.93 (3.70%)
Ex-dividend date03 May 2021
1y target est63.88
  • Sanofi to Buy mRNA Developer: ETFs in Focus
    Zacks

    Sanofi to Buy mRNA Developer: ETFs in Focus

    Sanofi has agreed to acquire U.S. biotech company Translate Bio to gain exposure in the mRNA vaccine space.

  • How This Historic FDA Approval Benefits Viatris
    Motley Fool

    How This Historic FDA Approval Benefits Viatris

    U.S. biopharmaceutical company Viatris (NASDAQ: VTRS) and its partner, Indian biopharma Biocon, announced on July 28 that the U.S. Food and Drug Administration (FDA) had approved their biosimilar insulin drug, Semglee, as an "interchangeable biosimilar" -- a direct alternative to Sanofi's (NASDAQ: SNY) blockbuster insulin drug, Lantus. Semglee is the first interchangeable biosimilar insulin product approved by the FDA.

  • Delta Variant Surge Brings Biotech ETFs in Focus
    Zacks

    Delta Variant Surge Brings Biotech ETFs in Focus

    The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.